GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Cash And Cash Equivalents

Sphere Medical Holding (LSE:SPHR) Cash And Cash Equivalents : £3.24 Mil (As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Cash And Cash Equivalents?

Sphere Medical Holding's quarterly cash and cash equivalents declined from Dec. 2015 (£10.03 Mil) to Jun. 2016 (£6.64 Mil) but then stayed the same from Jun. 2016 (£6.64 Mil) to Dec. 2016 (£3.24 Mil).

Sphere Medical Holding's annual cash and cash equivalents increased from Dec. 2014 (£3.70 Mil) to Dec. 2015 (£10.03 Mil) but then declined from Dec. 2015 (£10.03 Mil) to Dec. 2016 (£3.24 Mil).


Sphere Medical Holding Cash And Cash Equivalents Historical Data

The historical data trend for Sphere Medical Holding's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Cash And Cash Equivalents Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only 2.88 9.25 3.70 10.03 3.24

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 3.70 12.75 10.03 6.64 3.24

Sphere Medical Holding Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Sphere Medical Holding  (LSE:SPHR) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Sphere Medical Holding Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.